US FDA Discourages Off-Label Guidance Suits as Challenges To Entire Approval Authority
The US FDA says in a legal memo that its new guidance on scientific information on unapproved uses (SIUU) is “speech-enabling” and argues that challenges should be interpreted as attempts to roll back the approval process.
